Apr 08, 2024 13:45 JST

Source: NEC Corporation

NEC white paper proposes comprehensive process workflow for the application of AI-driven personalized cancer vaccines

TOKYO, Apr 8, 2024 - (JCN Newswire) - NEC Corporation (TSE: 6701) has released a white paper, "Towards the realization of AI drug development: Comprehensive process workflow for the commercial use of personalized cancer vaccines". This white paper introduces (1) a comprehensive process workflow that can be applied to a wide range of processes, starting from tumor sample collection to vaccine design, manufacturing, supply, and administration, (2) important perspectives for consideration in the workflow, and (3) advanced technologies that will contribute to the realization of the workflow.

Click here for details and downloads (registration is not required)URL: www.nec.com/en/global/solutions/ai-drug/publication/index.html

NEC is committed to taking on the challenge of realizing new cancer treatments by aiming to establish an accurate, reliable, and comprehensive process workflow that utilizes AI and security technologies.

In recent years, there have been growing expectations for personalized neoantigen cancer vaccines as a next-generation cancer therapy. Personalized neoantigen cancer vaccines are a type of cancer immunotherapy that targets neoantigens containing genomic mutations that are specific to each patient. NEC is working on the realization of personalized cancer vaccines by using one of its core technologies, AI, to identify target neoantigens from each individual patient’s genome data.

This white paper proposes a comprehensive process workflow for personalized cancer vaccines, from design to administration, and the perspectives that should be discussed in this flow. Furthermore, NEC's advanced ICT technologies are introduced to address these perspectives, and the possibility that the use of ICT technology will contribute to the realization of a platform for not only personalized cancer vaccines, but also for various cancer treatments are discussed.

About NEC Corporation

NEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of “Orchestrating a brighter world.” NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at https://www.nec.com.

Source: NEC Corporation
Sectors: MedTech

Copyright ©2024 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.

Related Press Release


VitalLife and Bumrungrad International Hospital in Thailand Launch NEC's FonesVisuas Test: First Major Deployment Outside Japan, Revolutionizing Disease Risk Prediction
July 18 2024 14:34 JST
 
NEC technology reliably measures sea levels from a greater distance
July 16 2024 16:45 JST
 
NEC transfers a portion of its shares in NEC Capital Solutions, an equity method affiliate
July 15 2024 15:58 JST
 
NEC awarded by e& for contributions to digital transformation and partnership strength
July 01 2024 22:00 JST
 
NEC and Ursa Space collaborate on satellite image analysis services using one of the world's largest virtual constellations
June 20 2024 12:20 JST
 
NEC hosts New Zealand Prime Minister Christopher Luxon
June 19 2024 18:00 JST
 
NEC develops compact millimeter-wave distributed antenna for Beyond 5G/6G through the development of a radio-over-fiber system enabling low power consumption
June 17 2024 15:06 JST
 
NEC announces external appointment of executive personnel
June 05 2024 16:43 JST
 
Successful demonstration of a superconducting circuit for qubit control within large-scale quantum computer systems
June 03 2024 17:58 JST
 
Celonis and NEC begin Proof of Concept Integrating Generative AI and Process Intelligence
May 28 2024 19:20 JST
 
More Press release >>

Latest Press Release


More Latest Release >>